Market closed

Revolution Medicines/$RVMD

14:30

16:10

17:45

19:25

21:00

1D1W1MYTD1Y5YMAX

About Revolution Medicines

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

Ticker

$RVMD

Sector

Health Care

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Redwood City, United States

Employees

490

Website

www.revmed.com

RVMD Metrics

BasicAdvanced

$7.9B

-

-$3.56

1.40 -

Price and volume

Market cap

$7.9B

Beta

1.4

52-week high

$60.59

52-week low

$25.93

Average daily volume

1.7M

Financial strength

Current ratio

14.244

Quick ratio

13.977

Long term debt to equity

Total debt to equity

5.536

Interest coverage (TTM)

-2,071.61%

Management effectiveness

Return on assets (TTM)

-28.56%

Return on equity (TTM)

-47.18%

Valuation

Price to revenue (TTM)

9,154.839

Price to book

4.56

Price to tangible book (TTM)

4.78

Price to free cash flow (TTM)

-12.325

Growth

Revenue change (TTM)

-97.16%

Earnings per share change (TTM)

7.43%

3-year revenue growth (CAGR)

-70.42%

3-year earnings per share growth (CAGR)

14.38%

What the Analysts think about RVMD

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Revolution Medicines stock.

RVMD Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

RVMD Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

RVMD News

AllArticlesVideos

Revolution Medicines to Present at 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewsWire·1 week ago

Insiders Are Loving These 6 Stocks Right Now

24/7 Wall Street·1 month ago

Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares

GlobeNewsWire·1 month ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $RVMD

$

Capital at risk

Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Revolution Medicines stock?

Revolution Medicines (RVMD) has a market cap of $7.9B as of January 15, 2025.

What is the P/E ratio for Revolution Medicines stock?

The price to earnings (P/E) ratio for Revolution Medicines (RVMD) stock is 0 as of January 15, 2025.

Does Revolution Medicines stock pay dividends?

No, Revolution Medicines (RVMD) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next Revolution Medicines dividend payment date?

Revolution Medicines (RVMD) stock does not pay dividends to its shareholders.

What is the beta indicator for Revolution Medicines?

Revolution Medicines (RVMD) has a beta rating of 1.4. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.